These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35346999)
1. CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer. Hong JK; Kim DY; Shin JS; Ryu YS; Moon JH; Koh DI; Lee S; Lee J; Lee WJ; Lee EY; Jung SA; Kim SC; Yu HN; Kim MJ; Hong SW; Park SS; Jung J; Kim SM; Kim EH; Jeong HR; Gong JH; Kim J; Kim TW; Jin DH Anticancer Res; 2022 Apr; 42(4):1813-1819. PubMed ID: 35346999 [TBL] [Abstract][Full Text] [Related]
2. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma. Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196 [TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of Janus kinases as drug targets for inflammatory diseases. Kwon S Front Immunol; 2022; 13():1075192. PubMed ID: 36569926 [TBL] [Abstract][Full Text] [Related]
5. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells. Lu J; Zhang L; Zhou H; Du Z; Zhang G Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653 [TBL] [Abstract][Full Text] [Related]
6. Quercetin as a JAK-STAT inhibitor: a potential role in solid tumors and neurodegenerative diseases. Zalpoor H; Nabi-Afjadi M; Forghaniesfidvajani R; Tavakol C; Farahighasreaboonasr F; Pakizeh F; Dana VG; Seif F Cell Mol Biol Lett; 2022 Jul; 27(1):60. PubMed ID: 35883021 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC. Kim DM; Kim MJ; Moon JH; Lee EY; Hong JK; Lee S; Koh DI; Ryu YS; Kim SM; Jung SA; Shin JS; Kim J; Park YS; Hong SW; Lee SH; Jung J; Park SS; Kim DY; Kim EH; Jeong HR; Gong JH; Kim J; Chan Kim S; Yu HN; Ki SY; Kim TW; Jin DH Biochem Biophys Res Commun; 2020 Jun; 527(1):305-310. PubMed ID: 32446385 [TBL] [Abstract][Full Text] [Related]
8. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease. Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215 [TBL] [Abstract][Full Text] [Related]
9. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer]. Yang X; Tang Z; Zhang P; Zhang L Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393 [TBL] [Abstract][Full Text] [Related]
10. MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway. Li LX; Lam IH; Liang FF; Yi SP; Ye LF; Wang JT; Guo WW; Xu M Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1487-1493. PubMed ID: 30840270 [TBL] [Abstract][Full Text] [Related]
11. Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines. Yar Saglam AS; Alp E; Elmazoglu Z; Menevse S Hum Exp Toxicol; 2016 May; 35(5):526-43. PubMed ID: 26183715 [TBL] [Abstract][Full Text] [Related]
12. Role of the JAK/STAT pathway in a streptozotocin-induced diabetic retinopathy mouse model. Cho CH; Roh KH; Lim NY; Park SJ; Park S; Kim HW Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3553-3563. PubMed ID: 35599279 [TBL] [Abstract][Full Text] [Related]
13. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway. Wang L; Kurosaki T; Corey SJ Oncogene; 2007 May; 26(20):2851-9. PubMed ID: 17146444 [TBL] [Abstract][Full Text] [Related]
14. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib. Emori T; Kasahara M; Sugahara S; Hashimoto M; Ito H; Narumiya S; Higashi Y; Fujii Y Eur J Pharmacol; 2020 Sep; 882():173238. PubMed ID: 32561292 [TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer. Karati D; Mahadik KR; Trivedi P; Kumar D Curr Cancer Drug Targets; 2022; 22(3):221-233. PubMed ID: 35232350 [TBL] [Abstract][Full Text] [Related]
17. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus. Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319 [TBL] [Abstract][Full Text] [Related]
18. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Lai SY; Johnson FM Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303 [TBL] [Abstract][Full Text] [Related]
19. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors. Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295 [TBL] [Abstract][Full Text] [Related]
20. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]